Cell Therapies Competitors and Similar CompaniesClear all
Cell Therapies's competitors and similar companies include Cimeio, Precigen, Mediphage Bioceuticals and ProQR Therapeutics.
 Cell Therapies Cell Therapies is a manufacturer of cell therapies, gene therapies, cellular immunotherapies, and regenerative medicine products. |  Cimeio Cimeio Therapeutics is a company developing proprietary cell-shielding technology and immunotherapies to treat diseases. |  Precigen Precigen (formerly known as Intrexon) is a biopharmaceutical company developing gene and cellular therapies for immuno-oncology, autoimmune, and infectious diseases. |  Mediphage Bioceuticals Mediphage Bioceuticals is a genetic medicine company developing a non-viral gene delivery vector platform. |  ProQR Therapeutics ProQR Therapeutics is a company that develops RNA therapies designed for patients suffering from genetic rare diseases. | |
Founding Date | Founding Date 2003 | Founding Date 2020 | Founding Date 1998 | Founding Date 2016 | Founding Date 2012 |
Type | Type Private | Type Private | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Melbourne, AU HQ | Locations Basel, CH HQ | Locations Germantown, US HQ Gent, BE Sioux Center, US | Locations Toronto, CA HQ | Locations Leiden, NL HQ Cambridge, US |
Employees | Employees 733% decrease | Employees 21 | Employees 601 | Employees 1023% decrease | Employees 166 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 246.6 m | Valuation ($) N/A | Valuation ($) 281.8 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $9.7m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) €15.9m (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income ($250.6m) (FY, 2025) | Net income N/A | Net income (€42.2m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 50m (about 4 years ago) | Latest funding round N/A | Latest funding round $ 3.5m (about 7 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 50m | Total funding raised $ 379m | Total funding raised $ 4.1m | Total funding raised $ 57.8m |
For sources of this data, please see the company profile
View Company Profiles
Cimeio
HQ
Basel, CH
Employees
21
Cimeio Therapeutics is a company developing proprietary cell-shielding technology and immunotherapies to treat diseases.
View companyPrecigen
HQ
Germantown, US
Employees
601
Precigen (formerly known as Intrexon) is a biopharmaceutical company developing gene and cellular therapies for immuno-oncology, autoimmune, and infectious diseases.
View companyMediphage Bioceuticals
HQ
Toronto, CA
Employees
10↓ 23% decrease
Mediphage Bioceuticals is a genetic medicine company developing a non-viral gene delivery vector platform.
View companyProQR Therapeutics
HQ
Leiden, NL
Employees
166
ProQR Therapeutics is a company that develops RNA therapies designed for patients suffering from genetic rare diseases.
View company